New Market Study, "Fibroblast Growth Factor Receptor 4 - Pipeline Review, H2 2016", Has Been Published
Global Markets Direct's, 'Fibroblast Growth Factor Receptor 4 (CD334 or FGFR4 or EC 2.7.10.1) - Pipeline Review, H2 2016', provides in depth analysis on Fibroblast Growth Factor Receptor 4 (CD334 or FGFR4 or EC 2.7.10.1) targeted pipeline therapeutics.
View full press release